pharmathene inc (PIP:NYSE Amex)
Mitchel B. Sayare Ph.D.
Chairman, Chairman of Governance & Nominating Committee and Member of Compensation Committee, PharmAthene, Inc.
|Age||Total Calculated Compensation||This person is connected to 21 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Mitchel B. Sayare, also known as Mitch, Ph.D. served as the Chief Executive Officer of ImmunoGen Inc. (a biotechnology company) from 1986 to January 1, 2009 and as its President from 1994 to July 29, 2008. From 1986 to 1992, Dr. Sayare served as the President of ImmunoGen Inc. From 1982 to 1985, Dr. Sayare served as a Vice President of Development at Xenogen Inc. Dr. Sayare has been the Chairman of PharmAthene, Inc. since July 15, 2011. Dr. Sayare served as the Chairman ...
One Park PlacePhone: 410-269-2600
Annapolis, Maryland 21401
Board Members Memberships*
Former Director, Chairman of Audit Committee and Member of Nominating Committee
Chairman, Chairman of Governance & Nominating Committee and Member of Compensation Committee
Temple University School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|David Aviezer Ph.D., M.B.A.||Chief Executive Officer, President, Executive Director and Chief Executive Officer of Protalix Ltd|
Protalix BioTherapeutics, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|